| scholarly article | Q13442814 |
| P356 | DOI | 10.1210/ENDO.142.11.8593 |
| P698 | PubMed publication ID | 11606473 |
| P50 | author | Randy J. Seeley | Q38546582 |
| P2093 | author name string | Woods SC | |
| D'Alessio DA | |||
| Lutz TA | |||
| Rushing PA | |||
| Hagan MM | |||
| Air EL | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 5035 | |
| P577 | publication date | 2001-11-01 | |
| P1433 | published in | Endocrinology | Q3054009 |
| P1476 | title | Inhibition of central amylin signaling increases food intake and body adiposity in rats | |
| P478 | volume | 142 |
| Q39008520 | A novel dual amylin and calcitonin receptor agonist, KBP-089, induces weight loss through a reduction in fat, but not lean mass, while improving food preference |
| Q48099438 | Activation of amylin receptors attenuates alcohol-mediated behaviours in rodents |
| Q44655643 | Addition of pramlintide to insulin therapy lowers HbA1c in conjunction with weight loss in patients with type 2 diabetes approaching glycaemic targets |
| Q36946078 | Amylin acts in the central nervous system to increase sympathetic nerve activity |
| Q47273571 | Amylin and its relation to insulin and lipids in obese children before and after weight loss |
| Q27003342 | Amylin at the interface between metabolic and neurodegenerative disorders |
| Q27311258 | Amylin modulates the mesolimbic dopamine system to control energy balance |
| Q28578065 | Amylin receptor blockade stimulates food intake in rats |
| Q38317203 | Amylin receptor signaling in the ventral tegmental area is physiologically relevant for the control of food intake |
| Q60690301 | Amylin, a peptide expressed by nociceptors, modulates chronic neuropathic pain |
| Q34959052 | Amylin, food intake, and obesity |
| Q91312520 | An amylin analogue attenuates alcohol-related behaviours in various animal models of alcohol use disorder |
| Q36307453 | Analysis of the ability of pramlintide to inhibit amyloid formation by human islet amyloid polypeptide reveals a balance between optimal recognition and reduced amyloidogenicity |
| Q37650208 | Antipsychotic-like actions of the satiety peptide, amylin, in ventral striatal regions marked by overlapping calcitonin receptor and RAMP-1 gene expression |
| Q36329000 | Binding Orientations and Lipid Interactions of Human Amylin at Zwitterionic and Anionic Lipid Bilayers |
| Q34717929 | Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus |
| Q33976258 | Central amylin acts as an adiposity signal to control body weight and energy expenditure |
| Q36979763 | Central control of body weight and appetite |
| Q37000812 | Central neural and endocrine mechanisms of non-exercise activity thermogenesis and their potential impact on obesity |
| Q41704295 | Cholesterol modulates the interaction of the islet amyloid polypeptide with membranes |
| Q36638737 | Cognitively impaired elderly exhibit insulin resistance and no memory improvement with infused insulin |
| Q37970941 | Control of energy homeostasis by amylin |
| Q37442584 | Control of food intake and energy expenditure by amylin-therapeutic implications |
| Q30399390 | Current trends in targeting the hormonal regulation of appetite and energy balance to treat obesity |
| Q43236384 | Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight |
| Q38113990 | Disulfide bonds in amyloidogenesis diseases related proteins |
| Q46448409 | Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes |
| Q44848283 | Effect of pramlintide on weight in overweight and obese insulin-treated type 2 diabetes patients |
| Q43963489 | Effects of amylin-related peptides on food intake, meal patterns, and gastric emptying in rats |
| Q29248785 | Exploring estrogenic activity in lung cancer |
| Q43866304 | Food intake and meal pattern in IAPP knockout mice with and without infusion of exogenous IAPP. |
| Q35280161 | General amyloid inhibitors? A critical examination of the inhibition of IAPP amyloid formation by inositol stereoisomers |
| Q35667150 | Gut-Brain Endocrine Axes in Weight Regulation and Obesity Pharmacotherapy |
| Q38294841 | Hypothalamic Amylin Acts in Concert with Leptin to Regulate Food Intake |
| Q35690970 | Incretins and amylin: neuroendocrine communication between the gut, pancreas, and brain in control of food intake and blood glucose |
| Q34449568 | Influence of a selective histamine H3 receptor antagonist on hypothalamic neural activity, food intake and body weight |
| Q48092573 | Islet Amyloid Polypeptide Membrane Interactions: Effects of Membrane Composition |
| Q37365646 | Leptin does not directly regulate the pancreatic hormones amylin and pancreatic polypeptide: interventional studies in humans |
| Q47288853 | Low-dose pramlintide reduced food intake and meal duration in healthy, normal-weight subjects |
| Q26774381 | Molecular Structure, Membrane Interactions, and Toxicity of the Islet Amyloid Polypeptide in Type 2 Diabetes Mellitus |
| Q37352232 | Neuroendocrine and physiological regulation of intake with particular reference to domesticated ruminant animals |
| Q34718618 | Neuronal receptor activity-modifying protein 1 promotes energy expenditure in mice |
| Q30243992 | Obesity: Current and potential pharmacotherapeutics and targets |
| Q35140241 | Pancreatic signals controlling food intake; insulin, glucagon and amylin |
| Q47270446 | Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight |
| Q36153252 | Pharmacological characterization of rat amylin receptors: implications for the identification of amylin receptor subtypes. |
| Q39006267 | Physiologic and Neural Controls of Eating |
| Q48400779 | Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study |
| Q34230460 | Rationally designed, nontoxic, nonamyloidogenic analogues of human islet amyloid polypeptide with improved solubility |
| Q30403705 | Regulation of appetite to treat obesity |
| Q99561829 | Systemic and Central Amylin, Amylin Receptor Signaling, and Their Physiological and Pathophysiological Roles in Metabolism |
| Q39234687 | The ability of insulin to inhibit the formation of amyloid by pro-islet amyloid polypeptide processing intermediates is significantly reduced in the presence of sulfated glycosaminoglycans |
| Q37722107 | The role of amylin in the control of energy homeostasis |
| Q42733549 | The role of the disulfide bond in the interaction of islet amyloid polypeptide with membranes |
| Q46947137 | The subfornical organ: a central target for circulating feeding signals. |
Search more.